Leading Independent Proxy Advisory Firm ISS Recommends

BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (

Related Keywords

Boston ,Massachusetts ,United States ,Russia ,Gurnet Point ,China ,Ukraine ,America ,Michael Lampe ,Jeffrey Stein ,Paratek Pharmaceuticals Inc ,Resistance Acquisition Inc ,Exchange Commission ,Linkedin ,Resistance Merger Sub Inc ,Us Department Of Health ,Novo Holdingsas Holdings ,Institutional Shareholder Services Inc ,Human Service Biomedical Advanced Research ,Development Authority ,Morrow Sodali ,Zai Lab ,Twitter ,Institutional Shareholder Services ,Gurnet Point Capital ,Novo Holdings ,Lead Independent Director ,North America ,Paratek Pharmaceuticals ,Resistance Merger Sub ,Resistance Acquisition ,Merger Agreement ,Proxy Statement ,Merger Sub ,Nasdaq Prtk ,Nc ,